Beam Therapeutics BEAM Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Beam Therapeutics's change in AP?
- Beam Therapeutics (BEAM) reported change in AP of $2.22M in Q1 2026.
- How has Beam Therapeutics's change in AP changed year-over-year?
- Beam Therapeutics's change in AP decreased by 41.6% year-over-year, from $3.79M to $2.22M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.